Skip Navigation

European Heart Journal 2002 23(16):1276-1281; doi:10.1053/euhj.2001.3117
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mills, J.D.
Right arrow Articles by Grant, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mills, J.D.
Right arrow Articles by Grant, P.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease

J.D. Millsf1, M.W. Mansfield and P.J. Grant

Academic Unit of Molecular Vascular Medicine, University of Leeds, U.K.

Received October 30, 2001; accepted November 21, 2001

Abstract

Aims To assess the possible role of certain coagulation factors and associated genetic polymorphisms in families in which coronary disease has occurred prematurely.

Methods and Results One hundred and eighty-five healthy male relatives aged 65 or less were recruited following the identification of 125 patients with confirmed, premature coronary artery disease and compared to a control group of 185 healthy, age-matched volunteers. None of the control subjects had a personal or family history of coronary artery disease. The relatives and controls were similar in terms of conventional coronary artery disease risk factors. Fibrinogen levels were elevated in relatives compared with controls and remained higher after adjustment for significant correlates, 3·0g.l–1 (2·9–3·1) vs 2·8g.l–1 (2·8–2·9),P =0·004. Factor VII coagulant activity and von Willebrand factor antigen did not differ between the groups nor were there any differences in genotype frequency for the fibrinogen Bß-455 G/A polymorphism or the factor VII promoter deletion/insertion and Arg-Gln coding polymorphisms.

Conclusions A significant increase in fibrinogen levels was demonstrated in the healthy, male, first-degree relatives of patients with severe coronary artery disease. Fibrinogen may be of particular importance in subjects who, other than their family history, appear to be at low risk in terms of conventional coronary artery disease risk factors. Copyright 2002 The European Society of Cardiology Published by Elsevier Science Ltd. All rights reserved.

Key Words: Family history, coronary artery disease, fibrinogen, factor VII, von Willebrand factor

f1 Correspondence: Dr Joseph D. Mills, Academic Unit of Molecular Vascular Medicine, G Floor, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Int J EpidemiolHome page
J. Yarnell, S. Yu, C. Patterson, F. Cambien, D. Arveiler, P. Amouyel, J. Ferrieres, G. Luc, A. Evans, and P. Ducimetiere
Family history, longevity, and risk of coronary heart disease: the PRIME Study
Int. J. Epidemiol., February 1, 2003; 32(1): 71 - 77.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.